These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9676592)

  • 41. Na(+), K(+)-ATPase content in skeletal muscle of dogs with pituitary-dependent hyperadrenocorticism.
    Schotanus BA; Meij BP; Vos IH; Kooistra HS; Everts ME
    Domest Anim Endocrinol; 2006 May; 30(4):320-32. PubMed ID: 16202554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment.
    Peterson ME; Altszuler N
    Am J Vet Res; 1981 Nov; 42(11):1881-3. PubMed ID: 7199880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of the addition of pasireotide to traditional adrenal-directed treatment for dogs with pituitary-dependent hyperadrenocorticism secondary to macroadenoma: 9 cases (2013-2015).
    Lottati M; Bruyette DS
    J Am Vet Med Assoc; 2018 Jun; 252(11):1403-1408. PubMed ID: 29772978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperadrenocorticism: treating dogs.
    Brown CG; Graves TK
    Compend Contin Educ Vet; 2007 Mar; 29(3):132-4, 136, 138 passim; quiz 144-5. PubMed ID: 17726933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitotane (o,p'-DDD) resistance in a dog with pituitary-dependent hyperadrenocorticism and phaeochromocytoma.
    Bennett PF; Norman EJ
    Aust Vet J; 1998 Feb; 76(2):101-3. PubMed ID: 9578778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COMPARISON OF TWO COARSE FRACTIONATED RADIATION PROTOCOLS FOR THE MANAGEMENT OF CANINE PITUITARY MACROTUMOR: AN OBSERVATIONAL STUDY OF 24 DOGS.
    Marcinowska A; Warland J; Brearley M; Dobson J
    Vet Radiol Ultrasound; 2015; 56(5):554-62. PubMed ID: 26129808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of diagnostic computerized tomography and radiation therapy in canine and feline hyperadrenocorticism.
    Mauldin GN; Burk RL
    Probl Vet Med; 1990 Dec; 2(4):557-64. PubMed ID: 2134074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors for outcome after transsphenoidal hypophysectomy in dogs with pituitary-dependent hyperadrenocorticism.
    Hanson JM; Teske E; Voorhout G; Galac S; Kooistra HS; Meij BP
    J Neurosurg; 2007 Oct; 107(4):830-40. PubMed ID: 17937231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
    Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of factors that influence survival in dogs with adrenal-dependent hyperadrenocorticism treated with mitotane or trilostane.
    Helm JR; McLauchlan G; Boden LA; Frowde PE; Collings AJ; Tebb AJ; Elwood CM; Herrtage ME; Parkin TD; Ramsey IK
    J Vet Intern Med; 2011; 25(2):251-60. PubMed ID: 21352377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors for dogs with granulomatous meningoencephalomyelitis: 42 cases (1982-1996).
    Muñana KR; Luttgen PJ
    J Am Vet Med Assoc; 1998 Jun; 212(12):1902-6. PubMed ID: 9638190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: a case report.
    Galac S; Kars VJ; Voorhout G; Mol JA; Kooistra HS
    Vet J; 2008 Jul; 177(1):141-3. PubMed ID: 17572120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hair chewing associated with suspected hyperadrenocorticism in a dog.
    Chastain CB
    J Am Vet Med Assoc; 1978 Mar; 172(5):573-4. PubMed ID: 632195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
    Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
    Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pituitary-dependent hyperadrenocorticism in a cat.
    Peterson ME; Steele P
    J Am Vet Med Assoc; 1986 Sep; 189(6):680-3. PubMed ID: 3019973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
    Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
    J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetes insipidus and hyperadrenocorticism associated with high plasma adrenocorticotropin concentration and a hypothalamic/pituitary mass in a dog.
    Ferguson DC; Biery DN
    J Am Vet Med Assoc; 1988 Oct; 193(7):835-9. PubMed ID: 2848001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
    Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
    Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.